Traditional Chinese medicinal liquor for treating phthisis and preparation method thereof

Abstract

The invention discloses traditional Chinese medicinal liquor for treating pulmonary tuberculosis and a preparation method thereof, and belongs to the field of traditional Chinese medicinal liquor. Thetraditional Chinese medicinal liquor is prepared from the following components in parts by mass: 35 to 48 parts of radix dipsaci, 20 to 30 parts of snakegourd leaves, 17 to 25 parts of radix stemonae, 11 to 18 parts of cortex lycii radicis, 11 to 18 parts of mulberry bark, 20 to 27 parts of hawk-tea, 7 to 15 parts of poria cocos, 7 to 15 parts of plantain herb, 5 to 9 parts of tragus berteronianus, 5 to 9 parts of raw folium artemisiae argyi and 800 to 1000 parts of Baijiu. The medicinal liquor is prepared by pretreatment, cleaning and soaking. The medicinal liquor has the technical effects that: (1) the components have a synergistic effect and have the effects of protecting the kidney, the liver and the spleen, treating the lung, relaxing muscles, stimulating blood circulation and protecting cardiovascular system; and (2) the medicine preparation is simple, the lung treatment is thorough, no calcification point is left, the lung is restored to a normal state before illness, medicinespermeate into each corner of each fine cell of the lung, and the retreatment on the dependent drug-resistant physique brought by the original long-term taking of western medicines and traditional Chinese medicines is perfected.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicinal wine, in particular to a traditional Chinese medicinal wine for treating pulmonary tuberculosis and a preparation method thereof. Background technique [0002] Pulmonary tuberculosis is a pulmonary infectious disease caused by Mycobacterium tuberculosis. The main clinical symptoms are cough, hemoptysis, chest pain, and hot flashes. It is contagious and insidious, posing a serious threat to human health; In recent years, due to the emergence of drug-resistant strains of tuberculosis bacteria, this ancient disease has revived. According to preliminary statistics, the number of patients in my country is increasing at a rate of 1% every year. Analyze its reason, mainly be streptomycin, isoniazid, pyrazinamide, rifampicin etc. as the medicine for treating pulmonary tuberculosis in the prior art, these medicines are big to the toxic and side effect of accepting the treatment patient...

AI Technical Summary

Problems solved by technology

Analyze its reason, mainly be streptomycin, isoniazid, pyrazinamide, rifampicin etc. as the medicine for treating pulmonary tuberculosis in the prior art, these medicines are big to the toxic and side effect of accepting the treatment patient of pulmonary tuberculosis, some patients cannot Tolerance of the side effects of western medicine, and intermittent, interruption or self-stop medicine, some are unable or unwilling to take western medicine because of liver or other system diseases, but there are also many patients who strictly abide by the " "Early, appropriate, regular, combined, and full-course" medication principles, but still can not be completely cured, this is the result of the emergence of drug-resistant strains of pulmonary tuberculosis

[0003] At present, there are many western medicines or traditional Chinese medicines for the treatment of pulmonary tuberculosis on the market. The formulas are complex or simple. Due to the different preparation of the original medicines, the curative effect varies greatly. The western medicines and traditional Chinese medicines have treatment methods such as oral administration and external application, excision of lesions, and chemotherapy. ) limitation, the treatment effect is not ideal and recurrent

Images